Generic competition · all medicines · read 12 November 2026
Is there a generic of Mometasone Furoate, and who makes it?
Mometasone Furoate appears in 7 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 11 generic makers listed as marketed across them. 3 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came between 14.9 and 18.5 years after the first brand approval. This is the Orange Book's listing, not a forecast.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.
- Mometasone Furoate appears in 7 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 11 generic makers listed as marketed across them.
- 3 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
- Where both are dated, the first generic approval came between 14.9 and 18.5 years after the first brand approval.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Spray, Metered, Nasal
Four or more generic makers listed
Brand listed as marketed: Nasonex 24hr Allergy. 4 generic makers with 4 generic products listed as marketed; the first generic approval is dated 22 March 2016.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Apotex Inc | 22 March 2016 | 1 |
| Amneal Pharmaceuticals | 3 April 2017 | 1 |
| Aurobindo Pharma Ltd | 18 March 2024 | 1 |
| Naspress Pharmaceutical Co Ltd | 15 May 2025 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Ointment, Topical
Four or more generic makers listed
Every brand product here is listed as discontinued. 5 generic makers with 5 generic products listed as marketed; the first generic approval is dated 18 March 2002.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Padagis Us Llc | 18 March 2002 | 1 |
| Encube Ethicals Private Ltd | 14 November 2003 | 1 |
| Fougera Pharmaceuticals Inc | 28 March 2005 | 1 |
| Cosette Pharmaceuticals Nc Laboratories Llc | 20 June 2006 | 1 |
| Torrent Pharmaceuticals Ltd | 13 July 2018 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Cream, Topical
One to three generic makers listed
Every brand product here is listed as discontinued. 2 generic makers with 2 generic products listed as marketed; the first generic approval is dated 21 December 2004.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Sun Pharma Canada Inc | 21 December 2004 | 1 |
| Cosette Pharmaceuticals Nc Laboratories Llc | 22 May 2006 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Lotion, Topical
One to three generic makers listed
Every brand product here is listed as discontinued. 3 generic makers with 3 generic products listed as marketed; the first generic approval is dated 6 April 2005.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | 6 April 2005 | 1 |
| Encube Ethicals Private Ltd | 21 November 2007 | 1 |
| Fougera Pharmaceuticals Inc | 29 November 2007 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Aerosol, Metered, Inhalation
Brand listed, no generic listed as marketed
Brand listed as marketed: Asmanex Hfa. No generic is listed as marketed.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Powder, Inhalation
Brand listed, no generic listed as marketed
Brand listed as marketed: Asmanex Twisthaler. No generic is listed as marketed.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Implant, Implantation
Brand listed, no generic listed as marketed
Brand listed as marketed: Sinuva. No generic is listed as marketed.
Patents and exclusivities still listed
- 29 November 2026Patent 7544192
- 12 June 2027Patent 8025635 drug product
- 3 October 2031Patent 10357640
- 8 February 2032Patent 8763222 drug product
- 13 March 2034Patent 10406332 drug product
- 24 November 2034Patent 10232152 drug product
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.